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RLF (relaxin-like factor), also known as INSL3 (insulin-like
peptide 3), is a novel member of the relaxin/insulin gene family
that is expressed in testicular Leydig cells. Despite the implicated
role of RLF/INSL3 in testis development, its native conformation
remains unknown. In the present paper we demonstrate for
the ﬁrst time that boar testicular RLF/INSL3 is isolated as a
monomeric structure with full biological activity. Using a series
of chromatography steps, the native RLF/INSL3 was highly
puriﬁedasasinglepeakinreverse-phaseHPLC.MS/MS(tandem
MS) analysis of the trypsinized sample provided 66% sequence
coverage and revealed a distinct monomeric structure consisting
of the B-, C- and A-domains deduced previously from the
RLF/INSL3 cDNA. Moreover, the N-terminal peptide was four
aminoacidresidueslongerthanpredictedpreviously.MSanalysis
of the intact molecule and PMF (peptide mass ﬁngerprinting)
analysis at 100% sequence coverage conﬁrmed this structure
and indicated the existence of three site-speciﬁc disulﬁde bonds.
RLF/INSL3 retained full bioactivity in HEK (human embryonic
kidney)-293 cells expressing RXFP2 (relaxin/insulin-like family
peptide receptor 2), the receptor for RLF/INSL3. Furthermore,
RLF/INSL3 was found to be secreted from Leydig cells into
testicular venous blood. Collectively, these results indicate that
boar RLF/INSL3 is secreted from testicular Leydig cells as a
B–C–A monomeric structure with full biological activity.
Key words: bioactivity, native conformation, relaxin-like
factor/insulin-likepeptide3(RLF/INSL3),tandemMS(MS/MS),
testis.
INTRODUCTION
RLF (relaxin-like factor), also known as INSL3 (insulin-like
peptide 3), is a novel member of the relaxin/insulin gene family
that was originally discovered by screening a boar testicular
cDNA library [1]. Since then, its cDNA has been cloned from
the testes of a number of mammalian species [2]. RLF/INSL3
has been implicated in the regulation of testicular function:
RLF/INSL3-knockout male mice exhibit cryptorchidism during
fetal development because of a developmental abnormality in the
gubernaculum, which results in abnormal spermatogenesis and
infertility [3,4]. Furthermore, RLF/INSL3 suppresses male germ
cell apoptosis in the rat testis [5], although its role in adults is still
unclear.
In contrast with other peptides from the relaxin/insulin family,
verylittleisknownaboutthenativeconformationofRLF/INSL3.
Nevertheless, based on predictions from the amino acid sequence
derived from its cDNA, it has been presumed that RLF/INSL3
is biosynthesized as a pro-protein (pro-RLF/INSL3) containing:
(i) a signal peptide that presumably permits the nascent protein
accesstotheendoplasmicreticulumbeforebeingexcised;and(ii)
A- and B-domains connected by a C-domain [2,6]. Furthermore,
pro-RLF/INSL3 is assumed to undergo proteolytic processing
to remove the C-domain peptide and then to mature to an A–
B heterodimer linked by two disulﬁde bonds to form an active
hormone like the other members of this group of peptides [2,6].
On the basis of this prediction, a synthetic peptide that consists of
an A–B heterodimer with site-speciﬁc sequential disulﬁde bonds
hasbeenproducedinsomespecies,includinghumans[7]andrats
[8]. The synthetic peptide stimulates cAMP production through
binding to its own receptor RXFP2 (relaxin/insulin-like family
peptide receptor 2), originally called LGR8 (leucine-rich repeat-
containingG-protein-coupledreceptor8)[9].Thisiscorroborated
by only one previous study which reports that native RLF/INSL3
is isolated as an A–B heterodimer from bovine testis [10].
However, there is no evidence as to whether the native
RLF/INSL3 of other species undergoes proteolytic processing to
dissociate the C-domain and then mature to an A–B heterodimer.
In fact, the RLF/INSL3 of tissue extracts from humans [11],
rats [12], horse [13], deer [14] and goats [15], as revealed by
Western blot analysis, appears to correspond in size with the pro-
RLF/INSL3 deduced from the cDNA sequences. This implies
that the native RLF/INSL3 of other species may not be processed
to an A–B heterodimer. Clarifying the native conformation of
RLF/INSL3 would be extremely meaningful not only for the
development of a speciﬁc immunoassay system for measuring
RLF/INSL3 in blood and body ﬂuids, but also for conducting
studies on the true physiological function of this hormone.
In the present study we puriﬁed native RLF/INSL3 from boar
testes and demonstrated for the ﬁrst time in any species that it
was isolated as a B–C–A monomeric structure with site-speciﬁc
disulﬁde bonds and full biological activity.
Abbreviations used: ACN, acetonitrile; DIG, digoxigenin; ECL, enhanced chemiluminescence; HEK, human embryonic kidney; INSL3, insulin-like
peptide 3; MALDI, matrix-assisted laser desorption ionization; MS/MS, tandem MS; PC1/3, prohormone convertase 1/3; PMF, peptide mass ﬁngerprinting;
RLF, relaxin-like factor; RXFP2, relaxin/insulin-like family peptide receptor 2; TBST-milk, Tris-buffered saline containing Tween 20 with 2% skimmed milk;
TF, transferrin; TFA, triﬂuoroacetic acid; TR-FIA, time-resolved ﬂuoroimmunoassay.
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EXPERIMENTAL
Chemicals and general methods
HPLC grade ACN (acetonitrile) and TFA (triﬂuoroacetic acid)
were purchased from Wako Pure chemicals and Peptide Institute
respectively. Sephadex G-50 (ﬁne) was obtained from GE
Healthcare Bio-Sciences. All other chemicals were of guaranteed
grade and were purchased from commercial sources. All DNA
constructs were veriﬁed by DNA sequencing, which was
performed by the sequencing service of Macrogen.
Animals and tissue sampling
Testes were collected from mature fertile Duroc boars at the
Shizuoka Swine and Poultry Experimental Station and at a local
slaughterhouse. The testes were cut into small cubes, rapidly
frozen in liquid nitrogen and stored at −80◦C until protein
extraction. Some of the samples were either ﬁxed in Bouin’s
solution and then parafﬁn-embedded for immunohistochemistry
or frozen with Tissue-TeK O.C.T. embedding compound (Sakura
Finetechnical) in liquid nitrogen for in situ hybridization.
Testicular venous blood was also collected from the spermatic
cord,whereasperipheralvenousbloodwastakenfromthejugular
vein. The blood samples were centrifuged at 4◦C for 10 min at
1500 g,a n dt h es e r u mw a ss t o r e da t−80◦C. Animal care and all
experimental procedures were performed in accordance with the
Health Guidelines for Care and Use of Experimental Animals at
Shizuoka University.
Protein concentrations
Protein concentrations were determined using the method of
Lowry–Folin [16], with BSA as a standard.
Anti-RLF/INSL3 antiserum
Anti-RLF/INSL3 antiserum (RLF-A-Ab808) used in the present
studywasgeneratedpreviouslybyourlaboratoryinNewZealand
White rabbits against the synthetic peptide of 15 amino acid
residues of the A-domain which shared 100% amino
acid homology among boar, bovine, sheep and goat RLF/INSL3
cDNAs. The speciﬁcity has been discussed in detail previously
[15,17].
Puriﬁcation of RLF/INSL3
Extraction
Boar testes (approximately 3400 g) were extracted according to
the method of Kohsaka et al. [18], which minimizes proteolysis
both by a low pH and by precipitating high molecular mass
proteases. The testes were ﬁnely ground in a meat grinder while
still frozen and homogenized at 4◦C in homogenizing medium
[2%(v/v)TFA,5%(v/v)formicacid,1%(w/v)sodiumchloride
and 1 M HCl] with an ULTRA-TURRAX® T25 Basic disperser
(IKA). The homogenate was then centrifuged at 28000 g for
20 min at 4◦C, and the supernatant was successively ﬁltrated
throughglassmicroﬁbreﬁlters(934-AH;Whatman)and0.45 μm
Durapore membrane ﬁlters (Millipore) in an ice bath. The ﬁltrate
was pumped (Perista pump SJ-1211H; Atto) at 5 ml/min through
Sep-Pak plus C18 Environmental Cartridges (Waters) that were
connected in series in an ice bath. After the cartridges
werewashedat4◦Cwith10%(v/v)ACNcontaining0.1%TFA,
the absorbed protein was eluted with 80% (v/v) ACN containing
0.1% TFA. The eluate was reduced using a rotary evaporator at
40◦C, freeze-dried and stored at −80◦C until gel ﬁltration.
Gel ﬁltration
The freeze-dried extract was dissolved in 20 mM ammonium
acetate buffer (pH 5.0) and applied to a Sephadex G-50 column
(2.5 cm×105 cm) equilibrated previously with the same buffer.
The ﬂow rate was maintained at 20 ml/h, and each 3-ml fraction
collectedwasmeasuredatanabsorbanceof280 nm.Thefractions
containing RLF/INSL3 were detected by dot-blot analysis with
anti-RLF/INSL3 antiserum, pooled and concentrated by freeze-
drying.
Cation-exchange FPLC
RLF/INSL3-positive fractions were puriﬁed by FPLC (Phar-
macia) on a TSKgel SP-5PW cation-exchange column
(5 mm×50 mm; Tosoh) equilibrated with 0.3 M NaCl in 25 mM
ammonium acetate buffer (pH 5.0) and eluted over 80 min with
a linear gradient of 0.3–0.9 M NaCl in the same buffer at a
ﬂow rate of 0.5 ml/min. The eluted peptides were monitored at
an absorbance at 280 nm, and 0.5-ml fractions were collected.
The fractions containing RLF/INSL3 were detected by dot-blot
analysis.
Reverse-phase HPLC
RLF/INSL3-positive fractions were further puriﬁed by HPLC
(model 4200; Hitachi) on an YMC-Pack ODS-AM column
(250 mm×4.6 mm; YMC) using a linear gradient system. The
solvents consisted of 0.1% TFA (solvent A) and 80% (v/v) ACN
in0.1%TFA(solventB).Thecolumnwasequilibratedwith33%
solvent B, and the elution was carried out over 26 min with a 33–
72% linear gradient of solvent B at a ﬂow rate of 1 ml/min. The
eluted peptides were monitored by their absorbance at 220 nm,
andthefractionsweremanuallycollectedandcheckedbydot-blot
and Western blot analyses.
Recovery
RLF/INSL3 content recovered from each step of the puriﬁcation
was measured by TR-FIA (time-resolved ﬂuoroimmunoassay)
using anti-RLF/INSL3 antiserum and recombinant RLF/INSL3,
which was expressed as proform of ∼16 kDa in Escherichia coli
as described previously [15,19], and was revealed as the EC50
values for the recombinant RLF/INSL3. The TR-FIA procedure
was performed according to the method of Ogine et al. [20].
Dot-blot and Western blot analyses
Samples were spotted directly on to a nitrocellulose
membrane (Bio-Rad Laboratories) using Bio-Dot SF (Bio-Rad
Laboratories), or separated by SDS/PAGE (14% gels) under
non-reducing conditions and transferred on to nitrocellulose
membranesusingasemi-drytransfercell(Bio-RadLaboratories).
The membranes were blocked in TBST-milk [TBS-T (Tris-
buffered saline containing Tween 20; 20 mM Tris/HCl, pH 7.4,
140 mM NaCl and 0.1% Tween 20) with 2% (w/v) skimmed
milk] and then incubated for 90 min with rabbit anti-RLF/INSL3
serum diluted 1:3000 in TBST-milk, followed by incubation for
1 hwithperoxidase-conjugatedgoatanti-rabbitIgG(ICN/Cappel)
diluted 1:8000 in TBST-milk at room temperature (25◦C).
Speciﬁc signals were detected using an ECL (enhanced
chemiluminescence) system (Amersham Biosciences). As a
loading control for Western blot analysis of serum samples,
TF (transferrin) was detected by sequential incubation with a
polyclonal antibody against TF (Sigma), peroxidase-conjugated
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goat anti-rabbit IgG (ICN/Cappel) and ECL (Amersham
Biosciences). The absorbance was measured by densitometric
scanning using the ImageJ software (http://rsb.info.nih.gov/ij/).
Protein digestion and nano-LC separation
RLF/INSL3 puriﬁed by a series of chromatography steps was
prepared to a concentration of approximately 2 μMi n2 0m M
ammonium acetate (pH 6.0). Trypsin (1 μl at 100 ng/μl) (Trypsin
Gold, MS grade; Promega) in 1 mM HCl was added to 20 μlo f
theRLF/INS3solution,andthesamplewasincubatedat37◦Cfor
6 h. The digestion was terminated by the addition of 1 μlo f5 0%
(v/v) acetic acid. The digest solution (4 μl) was submitted to a
Prominencenano-LCSystem(Shimadzu)coupledtoanAccuSpot
LC spotting system (Shimadzu). The mobile phases were solvent
A[ 0 . 1 % TFA in water/ACN (95:5, v/v)] and B [0.1% TFA
in water/ACN (10:90, v/v)]. Peptide digests were adsorbed
and desalted on the precolumn (Monolith, 0.2 mm×100 mm;
Monotech) with 0.1% TFA in water at a 35 μl/min ﬂow rate
(0–5min). Peptide digests were then separated using an analytical
column (Monolith, 0.1 mm×250 mm; Monotech) at a 1 μl/min
ﬂow rate with a gradient in which the amount of solvent B was
changed as follows: 5–8 min, 10%;2 2m i n ,4 0%;2 3m i n ,9 5%;
43 min, 95%;4 4m i n ,1 0%; and 59 min, 10%. The eluate was
recorded at 210 nm, mixed with the MALDI (matrix-assisted
laser desorption ionization) matrix solution [5 mg/ml CHCA
(α-cyano-4-hydroxycinnamicacid)in60%(v/v)ACNcontaining
0.1% TFA], and then directly spotted on to a 192-well MALDI
plate (Applied Biosystems).
MALDI-MS and MS/MS (tandem MS) analysis
MSandMS/MSanalysiswereperformedusinga4700Proteomics
Analyzer (Applied Biosystems). MS/MS analysis of an ofﬂine
spotted peptide digest sample was performed automatically with
a Plate Model external calibration. All MS/MS spectra were
combined, processed and database-searched with ProteinPilot
TM
Software (version 2.0.1; Applied Biosystems). For PMF (peptide
mass ﬁngerprinting) analysis, a digested sample that had not
undergone the column puriﬁcation process was mixed with the
matrix solution at a ratio of 1:3 (v/v) and analysed with external
calibration. For MS analysis of intact RLF/INSL3, a HPLC-
puriﬁed sample solution [∼10 μMi n1 0% (v/v) ACN containing
0.1% (v/v) TFA] was mixed with matrix solution at a ratio of
1:1 (v/v) and analysed in linear mode with internal calibration.
RLF/INSL3 bioassay based on the cAMP production in receptor
RXFP2-expressing HEK (human embryonic kidney)-293 cells
The full-length cDNA encoding receptor RXFP2 (GenBank®
accession number NM_080468) was generated by an RT (reverse
transcription)–PCR-based cloning method. Brieﬂy, total RNA
was extracted from the mouse uterus using ISOGEN (Nippon
Gene)andreverse-transcribedbyreversetranscriptase(Promega).
The PCR product (2225 bp) was ampliﬁed using the mRxfp2-F
primer 5
 -AGCTGAATTCGCCGCAATGTGGCTCCTACTTC-
3
  and the mRxfp2-R primer 5
 -AGCTGAATTCCTACGGGG-
AGACCGGCTTCAT (EcoRI sites underlined) with Vent DNA
polymerase (New England BioLabs) and cloned into a pT7-
Blue vector (TaKaRa Bio). Ampliﬁcation was performed using
a Dice PCR Thermal Cycler (TaKaRa Bio) with the following
programme: initial denaturation for 2 min at 94◦C, followed by
35 cycles of denaturation for 10 s at 98◦C and annealing and
extension for 2 min at 68◦C. The FLAG-tag sequence at the N-
terminus of RXFP2 was inserted by invert PCR. The RXFP2
cDNAbearingtheFLAGsequencewassubclonedwithEcoRIinto
a pdE vector derived from pdEGFP (BD Biosciences Clontech)
to generate the expression construct (2250 bp).
HEK-293 cells were maintained in DMEM (Dulbecco’s
modiﬁed Eagle’s medium; Sigma) supplemented with 10%
(v/v) FBS (fetal bovine serium; Bioﬁll Australian Pty),
1%(v/v)penicillin/streptomycin(Sigma)and2 mM L-glutamine
under a humidiﬁed environment containing 5% CO2 at 37◦C.
When the cells that were seeded in 96-well plates (Techno
Plastic Product) were 90% conﬂuent (2×10
5), transient
transfection of the expression construct or empty vector was
performed by Lipofectamine
TM 2000 (Invitrogen). After 24 h,
cells were incubated for 1 h in the presence of 0.05 mM
IBMX (isobutylmethylxanthine; Sigma) with or without isolated
RLF/INSL3 or synthetic human RLF/INSL3 peptide (R&D
Systems). Intracellular cAMP was detected with the cAMP
Biotrak enzyme immunoassay kit (GE Healthcare) and expressed
as a percentage of the maximum ligand response for receptor
RXFP2. All experiments were repeated at least three times using
cells from independent transfections.
In situ hybridization
Extraction of total RNA and ﬁrst-strand cDNA synthesis for
boar testis were performed as described above. The partial
sequence (324 bp) of boar RLF/INSL3 cDNA (GenBank®
accession number X68369) was PCR-ampliﬁed using forward
(5
 -CAGGAGGCGCCAGAGAAGCTGT-3
 ) and reverse (5
 -
GGGACAGAGGGTCAGCAAGTCTTG-3
 ) primers with Taq
DNA polymerase (New England BioLabs). cRNA probes for
in situ hybridization were prepared according to the method
of Kohsaka et al. [21]. Brieﬂy, the RLF/INSL3 construct in
pGEM-T Easy (Promega) was digested with NocI and SpeI, and
then the product was used as a template for SP6 and T7 RNA
polymerase (Promega) to generate antisense and sense
cRNA probes, which were labelled with DIG (digoxigenin)-11-
UTP (Roche Diagnostics). The speciﬁcity of the DIG-labelled
cRNA probes was veriﬁed by Northern blot analysis, in which
the anti-sense probe hybridized to a 0.9-kb RLF/INSL3 mRNA,
whereasthesenseprobeyieldednosignal.Testicularcryosections
(6 μm) were cut, and in situ hybridization was performed as
described previously [21].
Immunohistochemistry
For the localization of RLF/INSL3 in the testis, deparafﬁnized
testicular sections (4 μm) were immunostained with anti-
RLF/INSL3antiserumfollowedbyagoatanti-rabbitIgGpolymer
conjugated to peroxidase (DakoCytomation), as described
previously[19].Incontrast,forthelocalizationofreceptorRXFP2
in HEK-293 cells transfected with a RXFP2 cDNA construct, the
cells were immunostained with anti-FLAG M2 monoclonal IgG
(Sigma) followed by an Alexa Fluor® 488-conjugated goat anti-
mouse IgG (Invitrogen). Signals were examined under a BX50
Olympus microscope equipped with a CCD (charge-coupled
device) camera (DP50; Olympus).
Statistical analysis
Valuesarepresentedasthemeans+ −S.E.M.Resultswereanalysed
by one-way ANOVA, together with Fisher’s Protected Least
SigniﬁcantDifferencemultiplerangetesttocomparethemeansof
differentgroups.P<0.01wasconsideredstatisticallysigniﬁcant.
c   The Authors Journal compilation c   2012 Biochemical Society © 2011 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.268 I. Minagawa and others
Figure 1 Expression and puriﬁcation of boar testicular RLF/INSL3
(A) Veriﬁcation of RLF/INSL3 expression. In situ hybridization and immunohistochemistry revealed that RLF/INSL3 mRNA and protein were localized in the Leydig cells. Scale bar = 100μm. Ly,
Leydig cells; ST, seminiferous tubule. (B–D) Puriﬁcation of testicular RLF/INSL3. (B) Gel ﬁltration of boar testicular extract on a Sephadex G-50 column (2.5cm×105cm) in 20mM ammonium
acetate buffer (pH5.0). The fractions containing RLF/INSL3 immunoactivity (dark area) were revealed by dot-blot analysis. (C) Cation-exchange FPLC of the G-50 fraction on a TSKgel SP-5PW
column (5mm×50mm) eluted for 80min with a linear gradient of 0.3–0.9M NaCl in 25mM ammonium acetate buffer (pH5.0) at a ﬂow rate of 0.5 ml/min. RLF/INSL3 immunoactivity, as revealed
by dot-blot analysis, was found exclusively in the dark area of the efﬂuent curve. (D) Reverse-phase HPLC of the active fraction from cation-exchange FPLC on an YMC-Pack ODS-AM column (250
mm×4.6mm) by a 33–72% linear gradient of solvent B at a ﬂow rate of 1 ml/min. RLF/INSL3 was isolated as a single peak with a molecular mass of ∼12kDa, as revealed by Coomassie Brilliant
Blue-stained SDS/PAGE (CBB) and Western blot analysis (WB). DB, dot-blot analysis. OD indicates the densitometry of the dot-blot analysis.
RESULTS
Expression and puriﬁcation of boar testicular RLF/INSL3
RLF/INSL3mRNAandproteinwerevisualizedinLeydigcellsin
the boar testis using DIG-labelled cRNA probes complementary
to boar RLF/INSL3 mRNA and anti-RLF/INSL3 antiserum
respectively (Figure 1A). By using an extraction procedure that
minimized proteolysis, followed by gel ﬁltration (Figure 1B),
cation-exchange FPLC (Figure 1C) and reverse-phase HPLC
(Figure 1D), we isolated RLF/INSL3 from boar testes as a
single peak. The RLF/INSL3 eluted at each puriﬁcation step was
detected by dot-blot and/or Western blot analysis. The molecular
size of the isolated RLF/INSL3 was ∼12 kDa, as observed by
Western blotting (Figure 1D). The recoveries in the puriﬁcation
steps are summarized in Table 1.
Structural determination of isolated boar RLF/INSL3
The isolated RLF/INSL3 was digested at pH 6 to minimize
disulﬁde bond scrambling, which typically occurs during
enzymatic digestion if the pH is too high (pH 8). The resultant
peptide mixtures were then directly analysed by LC-MALDI-
MS/MS. When the MS/MS data were subjected to ProteinPilot
Software, boar pro-RLF/INSL3 sequence was distinctly assigned
as the top hit with 66% sequence coverage, including matches
to the C-terminal peptide (Figure 2A). The assigned peptides
corresponded to the B-, C- and A-domains of the boar pre-pro-
RLF/INSL3 deduced from the cDNA sequence [1]. The MS/MS
spectrumoftheM-H
+ precursorionatam/zvalueof1264.65was
identiﬁed as the N-terminal peptide of the B-domain, which
was four residues longer at the N-terminus than the B domain
deduced from the cDNA sequence (Figures 2A and 2B). This
amino acid extension (Arg-Ala-Pro-Ala) was assigned previously
to be a part of the signal peptide deduced from the cDNA
sequence. Because nano-LC-MS/MS analysis could have failed
todetectadditionalN-terminalaminoacids,MALDI-MSanalysis
of the intact isolated RLF/INSL3 was performed in linear
mode. Only one prominent peak was detected with external
calibration (results not shown). The observed mass of the
isolated RLF/INSL3 with internal calibration was 12031.25
(M-H
+, average mass) (Figure 2C). This was quite close
to the theoretical mass of 12031.80 (M-H
+, average mass:
C521H812N171O144S8), which was calculated from the deduced
sequence from cDNA without the signal peptide (residues
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Table 1 Summary of the puriﬁcation of testicular RLF/INSL3
The preparation was from 300g of frozen tissue as a starting material. The immunoactivity of RLF/INSL3 at each step of the puriﬁcation was measured by TR-FIA and was expressed as the EC50
values (ng/ml) for the recombinant RLF/INSL3. Similar results were obtained with two independent experiments.
Puriﬁcation step Total protein (μg) Immunoactivity (ng/ml) Yield (μg) Recovery (%) Puriﬁcation (fold)
Recombinant RLF/INSL3 – 22.2 – – –
Sep-Pak C18 extract 284 500 34 407 184 100 1
Gel ﬁltration 27 300 8707 70 38 4
Cation-exchange FPLC 199 170 26 14 202
Reverse-phase HPLC 11 22.2 11 6 1546
1–20), but with the three disulﬁde bonds. PMF analysis was
then performed to improve the sequence coverage and provide
information on the site-speciﬁc disulﬁde bonds. The mass peaks
in the PMF spectrum corresponded to 100% sequence coverage
for the deduced sequence from cDNA without the signal pep-
tide and indicated the existence of the three predicted disulﬁde
bonds, namely, one inter-peptide disulﬁde bond on T5–T12 and
one inter-peptide and one intra-peptide disulﬁde bond on T3-T11
(Figures 2A and 2D). The RMS (root mean square) mass error of
the monoisotopic peaks was 21 p.p.m. Other peaks that represent
disulﬁde bond scrambling were not observed in the spectra
(Figure3).TheT3–T5(m/z1567.78),T5–T11(m/z1578.68),T3–
T12 (m/z 2005.00) and T11–T12 (m/z 2015.90) pairings indicated
scrambling, but were observed only in the PMF spectra acquired
from the sample trypsinized in the basic buffer condition (20 mM
ammoniumbicarbonate,pH 8.0,for2or6 h)(Figure3).Therefore
the three assigned disulﬁde bond pairings, which were acquired
from the sample digested at pH 6 for 6 h, are considered to be
the original linkage pattern. These observations from the PMF
spectrum at 100% sequence coverage were consistent with the
obtained molecular mass of the isolated RLF/INSL3 without any
other post-translational modiﬁcations. We thus conclude that the
primary structure of boar testicular RLF/INSL3 is a monomeric
structure consisting of the 26-residue A-, 36-residue B- and
49-residue C-domains, in which the C-domain does not undergo
proteolytic dissociation, and the A- and B-domains are site-
speciﬁcally linked by three disulﬁde bonds (Figure 2E).
Biological activity of isolated RLF/INSL3
HEK-293 cells were transfected with a RLF/INSL3 receptor
RXFP2 cDNA construct (RXFP2-expressing HEK-293 cells)
to examine the biological activity of the isolated RLF/INSL3.
The cell-surface expression of RXFP2 was observed
immunohistochemically with a FLAG-tag antibody (Figure 4A).
Treatment of the RXFP2-expressing HEK-293 cells with the
isolated boar RLF/INSL3 resulted in a dose-dependent increase
in intracellular cAMP production, with an EC50 value of
approximately 5 nM (Figure 4B). This was comparable with
the EC50 values of the synthetic A–B heterodimeric human
RLF/INSL3 peptide (Figure 4B). In contrast, the isolated
RLF/INSL3 and synthetic RLF/INSL3 (results not shown) had
no effect on cells transfected with an empty vector (Figure 4B).
These results indicated that full bioactivity was present in the
isolated RLF/INSL3.
Secretion of RLF/INSL3 from Leydig cells into blood
Western blot analysis of testicular venous serum and peripheral
serum clearly demonstrated the 12 kDa immunoreactive
RLF/INSL3 protein corresponding with the molecular mass
of the RLF/INSL3 isolated from the testis (Figure 5A).
Furthermore, the relative level of RLF/INSL3 detected in
testicularvenousserumwassigniﬁcantly9-foldhigher(P<0.01)
than that in peripheral serum (Figure 5B). These results indicate
that RLF/INSL3 is secreted into the circulation by Leydig cells.
DISCUSSION
The present study demonstrates for the ﬁrst time in any species
that RLF/INSL3 is secreted from testicular Leydig cells as a
monomeric protein with biological activity.
On the basis of the predictions from the cDNA sequences,
the structure of RLF/INSL3 has been assumed to be an A–B
heterodimer [2,6]. However, there is only one report concerning
a bovine model of a native RLF/INSL3 that was puriﬁed from
testes and characterized as an A–B heterodimer either by protein
sequencing or by amino acid composition [10]. In the present
study,afterpurifyingtheproteinusingaseriesofchromatography
steps and performing MS and MS/MS analysis, we demonstrated
that the native RLF/INSL3 isolated from boar testes is a 12 kDa
monomeric structure comprising three domains B–C–A, in which
the C-domain does not undergo proteolytic processing. This
ﬁnding is consistent with the molecular size of RLF/INSL3 in
other species corresponding with pro-RLF/INSL3, as deduced
from their cDNA sequences [11–15]. However, it is not clear
why boar RLF/INSL3 is present as a B–C–A monomeric form,
unlike an A–B heterodimeric form of bovine RLF/INSL3. One
explanation is that there are differences in the post-translational
regulatory events between these species. Insulin and relaxin,
which belong to the same family as RLF/INSL3, are known to
undergo processing of prohormone by cleavage of the B-chain/
C-peptide junction by PC1/3 (prohormone convertase 1/3), which
is one of the processing enzymes [22,23]. Recently, we found that
no PC1/3 transcripts were expressed in boar testes at any of the
developmental stages [19]. Therefore it is reasonable to suggest
that the A–B heterodimeric RLF/INSL3 is not produced in the
boar testis due to a lack of the enzyme required for processing
the pro-RLF/INSL3, unlike the situation in bovines.
InadditiontotheB–C–Amonomericstructure,werevealedthat
the B-domain of the isolated boar RLF/INSL3 had an additional
four residues at the N-terminus compared with that deduced
from the cDNA sequence [1]. A similar ﬁnding was also seen
in bovine RLF/INSL3, but only 20% of the B-chains had a
ﬁve-residue extension at the N-terminus [10]. Signal peptides
control the entry of virtually all proteins into the secretory
pathway and are cleaved off during the transport of the nascent
proteins into the endoplasmic reticulum. The common structural
features of signal peptides are a positively charged N-terminus, a
central hydrophobic region, and a C-terminal region with small
and neutral amino acids at positions −3a n d−1 (relative to
the cleavage site) [24,25]. On the basis of this −3,−1r u l e ,
it was thought that the RLF/INSL3 signal peptide deduced
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Figure 2 MS and MS/MS analysis for the structural determination of isolated boar RLF/INSL3
(A) Amino acid sequence of boar pre-pro-RLF/INSL3 deduced from the cDNA sequence and the peptides assigned by MALDI-MS/MS analysis of the isolated boar RLF/INSL3. Assigned peptides
were recognized with a high score of 66% sequence coverage of the A-, B- and C-domains deduced from the cDNA [1]. (B) MALDI-MS/MS spectra of the M-H+ precursor ion at a m/z value of
1264.65. Sequential product ions in both the b-a n dy-series were successfully observed. The assigned peptide was the N-terminal peptide of the B-domain, which was four residues longer at the
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Figure 3 Scrutiny of disulﬁde bond scrambling in the digestion of isolated RLF/INSL3 under basic buffer conditions
(A) PMF spectraofthesamplestrypsinized in 20 mMammoniumacetate (pH6.0)(top panel)and 20mMammoniumbicarbonate(pH8.0) (middleandbottom panels).Theunderlinedpeptide(T11)
represents an intra-peptide disulﬁde bond. Predicted mass values are indicated with asterisks. (B) Peak intensities of the observed disulﬁde-bond-containing peptides in PMF spectra. Percentages
were calculated using each peak intensity (peak height). Mass values in the table are calculated m/z (M-H+).
from the cDNA would be cleaved between alanine and proline
residues (in bold) within the sequence APAPAQE [1]. However,
the four-residue extension of the B-domain was produced by
cleavage between serine and arginine residues (in bold) within
ALSRAPAPAQE. The −3a n d−1r e s i d u e si nA L S R A P A P A Q E
are small and neutral, which matches the criteria for cleavage
[24,25]. Thus it is clear that the signal peptidase recognized this
part as a cleavage site.
It is also important to demonstrate whether site-speciﬁc
disulﬁde bonds reside in the isolated RLF/INSL3. The high pH
conditions (pH 8) most frequently used in enzymatic digestion
can promote disulﬁde scrambling [26], and the positively charged
amino acids located close by or adjacent to the cysteine residues
can greatly enhance disulﬁde exchange reactions in random-coil
proteins up to 1×10
6-fold in rate constant [27]. In fact, the
enzymatic digestion of certain peptides containing such cysteine
residues in basic buffer conditions instantly causes disulﬁde bond
scrambling before the peptide begins to be digested, thereby
requiring enzymatic digestion under neutral or acidic buffer
conditions for the determination of disulﬁde pairings [28]. In the
present study, when the primary structure analysis was performed
underdigestionconditionsatpH 6.0usingammoniumacetate,the
PMF analysis resulted in the exclusive detection of two predicted
disulﬁde-linked peptides, namely, T3–T11 and T5–T12. Mean-
while PMF analysis of the sample trypsinized at pH 8.0 using
20 mMammoniumbicarbonaterecognizedseveraldisulﬁdebond
scrambling.However,theseunpredictedpeptidesanddimerswere
not observed under digestion conditions at pH 6.0, but only under
thoseatpH 8.0,withthepeakintensityincrementallyincreasingin
atime-dependentmanner(SeeFigure3).Itisthereforereasonable
to conclude that the two predicted peptides without the peak
intensity increments are the original disulﬁde-linked peptides. As
inboars,bovineRLF/INSL3wasshownbyHPLCanalysistohave
twoprominentpeakscorrespondingwithdisulﬁde-linkedpeptides
conﬁrmed using synthetic peptides, as reported by B¨ ullesbach
and Schwabe [10], who carried out enzymatic digestion under
basic buffer conditions using 50 mM ammonium bicarbonate
for 30 min. Taken together with the present ﬁnding that the
original disulﬁde linkages of the isolated boar RLF/INSL3 were
still retained predominantly at least up to 2 h after digestion at
pH 8.0,thetwodisulﬁde-linkedpeptidesobtainedfromtheshorter
digestion time in the bovine RLF/INSL3 [10] appear to reveal the
original disulﬁde-linkedpeptides.Moreover,the disulﬁdelinkage
patternofT3–T11(oneinter-andoneintra-peptidedisulﬁdebond)
couldbeconsideredidenticalwiththatdeterminedexperimentally
in bovine RLF/INSL3 [10] because of the structural similarity of
the relaxin/insulin family peptides.
RLF/INSL3 mediates its effect by stimulating cAMP
production through the cell-surface receptor RXFP2 [9]. Using
a reliable bioassay system based on cAMP production in
N-terminus than the B-domain deduced from the cDNA sequence. (C) Linear mode MALDI-MS spectra of standard proteins (upper panel) and isolated RLF/INSL3 with internal calibration (lower
panel). The calibrants were bovine insulin (M-H+:C 254H378N65O75S6)a n dE. coli-oxidized thioredoxin (M-H+:C 528H837N132O159S3). (D) PMF of isolated RLF/INSL3. The acquired sequence
coverage was 100% for the deduced sequence from cDNA without the signal peptide (residues 1–20). The two peptides peaks with disulﬁde bonds corresponded with the predicted information,
namely, T5–T12 (one inter-peptide) and T3–T11 (one inter- and one intra-peptide) (see A). T3, T5, T12 and T11 were attributed to the peptides containing sulfhydryl groups resulting from disulﬁde
bond cleavage by in-source fragmentation during the MALDI process [34]. (E) Primary structure of boar RLF/INSL3 determined by MS/MS and MS analyses.
c   The Authors Journal compilation c   2012 Biochemical Society © 2011 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.272 I. Minagawa and others
Figure 4 Biological activity of isolated RLF/INSL3
(A) The RLF/INSL3 receptor RXFP2 was transfected into HEK-293 cells for detecting the
biological activity of RLF/INSL3. RXFP2 is expressed on the cell surface in RXFP2-expressing
HEK-293cells,butisnotdetectedinthecellstransfectedwithanemptyvector(Control/HEK293).
(B)StimulationofcAMPproductionbyRLF/INSL3inRXFP2-expressingHEK-293cells.Isolated
RLF/INSL3()stimulateddose-dependentcAMPproductionwithEC50 valuescomparablewith
those of the synthetic A–B heterodimeric human RLF/INSL3 (), indicating the retention of
full bioactivity. In contrast, isolated RLF/INSL3 did not stimulate cAMP production in the
control/HEK293 (). cAMP production was expressed as a percentage of the maximum
isolated RLF/INSL3 or synthetic human RLF/INSL3 peptide response for RXFP2. Results are
means+ −S.E.M. for three independent experiments.
RXFP2-expressing HEK-293 cells, we were able to show
that the isolated RLF/INSL3 stimulated dose-dependent cAMP
production with an EC50 value of approximately 5 nM. This
was quite similar to the EC50 value of the synthetic A–
B heterodimeric human RLF/INSL3 peptide, revealing that
bioactivity fully resides in the isolated RLF/INSL3. Furthermore,
Western blot analysis of testicular venous serum and peripheral
serum demonstrated that RLF/INSL3 secreted was present as the
12 kDa of molecular nature in serum, revealing that RLF/INSL3
is not processed in the circulation after secretion. Therefore
RLF/INSL3 differs from insulin, in which the prohormone
undergoes proteolytic processing to form the active hormone,
but is quite similar to IGFs (insulin-like growth factors), in which
the proforms are not processed and have full bioactivity [29]. In
addition, boar RLF/INSL3 differs from porcine relaxin in the
point that is not processed into two-chain peptides, although
a recombinant primate pro-relaxin has full biological activity
[30].
The present study revealed that monomeric RLF/INSL3
produced by Leydig cells is secreted into the circulation by
showing the evidence that RLF/INSL3 levels in the testicular
Figure 5 Secretion of RLF/INSL3 from Leydig cells into blood as revealed
by Western blot analysis
(A) A representative Western blot analysis of testicular venous serum (TVS) and peripheral
serum (PS). For each lane, 12.5μl of the serum was applied. (B) The relative level of each
message normalized to that of TF. The relative level of the RLF/INSL3 content was 9-fold higher
(P <0.01)intesticularvenousserumthanthatinperipheralserum.Resultsaremeans+ −S.E.M.
for four animals.
vein were much higher than those in the peripheral blood. This
ﬁnding is in good agreement with that of human RLF/INSL3, as
shown by Ferlin and Foresta [31], who revealed that RLF/INSL3
is an endocrine factor. In contrast, receptor RXFP2 mRNA
and/or protein have been shown to be expressed in Leydig
cells and seminiferous tubule epithelial cells in adult testes of
some species, including humans [5,17,32,33]. There is also
evidencethatRLF/INSL3suppressesgermcellapoptosisintherat
testis [5], whereas the treatment of mouse Leydig TM3 cells with
RLF/INSL3 in vitro induces cell proliferation [33]. Collectively,
these ﬁndings suggest that the RLF/INSL3 produced by Leydig
cells functions as an autocrine and/or paracrine factor in Le-
ydig cells and seminiferous tubule epithelial cells. Unfortunately,
it remains presently unknown what effects RLF/INSL3 actually
exertsinboars.However,themonomericRLF/INSL3seemstobe
physiologicallyrelevantsinceboarRLF/INSL3isindeedsecreted
from testicular Leydig cells as a monomeric structure with biolo-
gicalactivity.Inthepresentstudy,therefore,theclariﬁcationofthe
native conformation of RLF/INSL3 will lead a development of a
speciﬁc immunoassay system measuring the monomeric
RLF/INSL3inbloodandbodyﬂuids,wherebytheyetunidentiﬁed
paracrine,endocrineand/orautocrineaspectsofRLF/INSLcanbe
exploredandprovideinsightintothepotentialroleofRLF/INSL3
in boar testicular function.
In conclusion, we have isolated native RLF/INSL3 from
boar testes and demonstrated for the ﬁrst time that the native
RLF/INSL3 is a B–C–A monomeric structure with full biological
activity.
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